See inside every stock. Pro
S&P 5007,757▲ 0.58%Nasdaq26,703▲ 1.05%Dow Jones52,856▲ 0.69%Nasdaq 10029,823▲ 1.13%VIX16.68▼ 3.64%US Dollar101.69▼ 0.01%Gold spot4,114▼ 0.44%WTI99.24▲ 2.15%
← TTT page
XStocksXray
Market X-Ray report · 21 October 2026

Titomic Ltd (TTT)

Australian Securities Exchange · Australia · prices in AUD · close of 21 Oct 2026

Key indicators

Last closeAUD 0.130
52-week range0.098 – 0.320
Return, 1 month / 3 months+4.0% / −27.8%
Return, 1 year / 3 years−49.0% / +766.7%
TrendBelow its 200-day average
RSI (14)55
Volatility (1 year)76.7%
Worst drawdown (1 year)-67.7%
Average daily value traded0.32M AUD
Dividend yield–

Market X-Ray price-based

31/ 100 · High confidence · ahead of 24% of stocks on this exchange
Trend19
Momentum14
Stability (higher is calmer)37
Liquidity72
Income–

Five-year price chart navy: price · brown: 200-day average

-0.010.090.190.280.382021-102023-012024-052025-072026-10

About the company

Titomic is an Australian additive manufacturing company that develops metal deposition technology for industrial customers. Its core process sprays metal powders at high speed to coat or build up metal components, and the company supplies related equipment and services. Customers come from defence, aerospace, mining and general manufacturing, and the business is based in Australia with operations aimed at international industrial markets.

The shares are listed on the Australian Securities Exchange in Australia under the code TTT, and the price on this page is in Australian dollars (AUD). Our records, which start in 2019, show no dividend payments for it. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.

Summary

Titomic Ltd (TTT) trades on the Australian Securities Exchange in Australia. It last closed at AUD 0.130 on 21 October 2026.

Its price-based Market X-Ray is 31 out of 100 (a weak price profile), ranking 1,371 of 1,815 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.

Over the last year the price fell 49.0% and over the last three months it fell 27.8%. Returns are price returns, dividends not included.

Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.

stocksxray.com · page 1
XStocksXray
Titomic Ltd (TTT)

The five lenses in numbers each metric is ranked against the other stocks on Australian Securities Exchange

Lens and metricValueScoreReading
Trend19 · WeakBelow its long-term averages and far from its highs.
Above 200-day average-36.3%
From 52-week high-58.1%
Momentum14 · WeakLagging most stocks on this exchange.
3-month return-27.8%
6-month return-55.2%
12-month return, skipping the last month-51.0%
Stability (higher is calmer)37 · WeakVolatile, with deep drawdowns.
Volatility, 1 year (lower is calmer)76.7%
Worst drawdown, 1 year (smaller is calmer)-67.7%
Liquidity72 · StrongTrades actively.
Average daily value traded0.32M AUD
Zero-volume days3.3%
Income–Pays no dividend.
Dividend yield–
Years with dividends0

Strengths

  • Liquidity: Trades actively.

Weak spots

  • Trend: Below its long-term averages and far from its highs.
  • Momentum: Lagging most stocks on this exchange.
  • Stability (higher is calmer): Volatile, with deep drawdowns.

Returns

1 week+30.0%
1 month+4.0%
3 months−27.8%
6 months−55.2%
1 year−49.0%
3 years+766.7%
5 years+15.0%

Signals

50-day / 200-day average0.132 / 0.204
Golden / death cross (60 days)None
New 52-week highNo
Bullish RSI divergenceNo
Average daily range (ATR)0.012

Technical summary

DailyBearish5 bullish · 1 neutral · 10 bearish
WeeklyStrongly bearish1 bullish · 1 neutral · 10 bearish
MonthlyStrongly bearish0 bullish · 1 neutral · 7 bearish

How to read this report

Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Australian Securities Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.

stocksxray.com · page 2 · generated 22 Oct 2026